Business & Technology News » Blog Archive » Agendia Presents New Data on the Biological Characteristics of Patients within Extreme Low Risk and High Risk MammaPrint Subgroups at the European Society for Medical Oncology (ESMO)

29 Sep 2019

Agendia Presents New Data on the Biological Characteristics of Patients within Extreme Low Risk and High Risk MammaPrint Subgroups at the European Society for Medical Oncology (ESMO)

Author: admintech | Filed under: Press Release

IRVINE, Calif. and AMSTERDAM, Sept. 29, 2019 /PRNewswire/ — Agendia Inc., a world leader in precision oncology for breast cancer, will present new data from their on-going clinical research at the European Society for Medical Oncology (ESMO) Congress 2019, taking place from September 27…

This entry was posted on Sunday, September 29th, 2019 at 7:25 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Agendia Presents New Data on the Biological Characteristics of Patients within Extreme Low Risk and High Risk MammaPrint Subgroups at the European Society for Medical Oncology (ESMO)

Categories